{"id":60280,"date":"2025-05-30T09:01:30","date_gmt":"2025-05-30T09:01:30","guid":{"rendered":"https:\/\/www.pantheregroup.com\/2025\/05\/30\/european-shares-rise-on-ecb-rate-cut-hopes\/"},"modified":"2025-05-30T09:01:30","modified_gmt":"2025-05-30T09:01:30","slug":"european-shares-rise-on-ecb-rate-cut-hopes","status":"publish","type":"post","link":"https:\/\/www.pantheregroup.com\/2025\/05\/30\/european-shares-rise-on-ecb-rate-cut-hopes\/","title":{"rendered":"European Shares Rise On ECB Rate Cut Hopes"},"content":{"rendered":"
<\/div>

\n<\/p>\n

\n

European stocks traded higher on Friday despite the latest U.S. court rulings on President Trump’s “Liberation Day” tariffs adding another layer of uncertainty. <\/p>\n

“We are already negotiating in [a] quite uncertain environment, with things changing quite rapidly,” Valdis Dombrovskis, European Union commissioner for economy<\/span>, told CNBC’s Karen Tso.<\/p>\n

He described the tariff situation as “urgent,” and reiterated that the EU was committed to agreeing to a negotiated deal with the U.S. <\/p>\n

Meanwhile, investors shrugged off data from Destatis showing that German retail sales decreased 1.1 percent on a monthly basis in April, in contrast to the 0.9 percent rise in March. Sales were expected to grow 0.3 percent.<\/p>\n

Year-on-year, retail sales growth softened to 2.3 percent from 3.3 percent a month ago.<\/p>\n

Elsewhere, Spanish inflation fell below the European Central Bank’s 2 percent target in May and inflation data from a slew of German states signaled weakening inflationary pressures, raising the odds of another interest rate cut by the European Central Bank when it next meets on June 5.<\/p>\n

The pan European STOXX 600 rose half a percent to 550.63 after falling 0.2 percent in the previous session. <\/p>\n

The German DAX climbed 0.8 percent, France’s CAC 40 edged up by 0.3 percent and the U.K.’s FTSE 100 added 0.6 percent. <\/p>\n

Pharmaceutical firm Sanofi SA slumped 6 percent after reporting mixed results from two phase 3 trials of its investigational chronic obstructive pulmonary disease (COPD) treatment, Itepekimab.<\/p>\n

Sirius Real Estate gained about 1 percent after selling its Pfungstadt park for \u20ac30 million.<\/p>\n

Drax Group jumped 2.2 percent. The renewable energy company has announced the lapse of its cash offer for the entire issued share capital of HEIT. <\/p>\n<\/p>\n

Market Analysis<\/p>\n<\/div>\n